These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 19509217)
1. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. Wakita D; Chamoto K; Ohkuri T; Narita Y; Ashino S; Sumida K; Nishikawa H; Shiku H; Togashi Y; Kitamura H; Nishimura T Carcinogenesis; 2009 Aug; 30(8):1408-15. PubMed ID: 19509217 [TBL] [Abstract][Full Text] [Related]
2. STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo. Kaganoi J; Watanabe G; Okabe M; Nagatani S; Kawabe A; Shimada Y; Imamura M; Sakai Y Ann Surg Oncol; 2007 Apr; 14(4):1405-15. PubMed ID: 17195908 [TBL] [Abstract][Full Text] [Related]
3. [A study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice]. Ren T; Liang YJ; Cai YY; Li CY; Mei J; Yuan ZH; Tao MF; Tian M; Zhao B Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):46-50. PubMed ID: 18366907 [TBL] [Abstract][Full Text] [Related]
4. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice. Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699 [TBL] [Abstract][Full Text] [Related]
5. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466 [TBL] [Abstract][Full Text] [Related]
7. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. Crowe NY; Smyth MJ; Godfrey DI J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876 [TBL] [Abstract][Full Text] [Related]
8. Reserpine and carcinogenesis: inhibition of carcinoma formation in mice. Lupulescu A J Natl Cancer Inst; 1983 Nov; 71(5):1077-83. PubMed ID: 6580485 [TBL] [Abstract][Full Text] [Related]
9. Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis. Hayakawa Y; Rovero S; Forni G; Smyth MJ Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9464-9. PubMed ID: 12867593 [TBL] [Abstract][Full Text] [Related]
10. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. Paget C; Bialecki E; Fontaine J; Vendeville C; Mallevaey T; Faveeuw C; Trottein F J Immunol; 2009 Feb; 182(4):1846-53. PubMed ID: 19201836 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis. Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K Carcinogenesis; 2005 Dec; 26(12):2116-22. PubMed ID: 16051640 [TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo. Thawani N; Tam M; Chang KH; Stevenson MM Exp Hematol; 2006 Nov; 34(11):1451-61. PubMed ID: 17046564 [TBL] [Abstract][Full Text] [Related]
13. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity. Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059 [TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Aoi J; Endo M; Kadomatsu T; Miyata K; Nakano M; Horiguchi H; Ogata A; Odagiri H; Yano M; Araki K; Jinnin M; Ito T; Hirakawa S; Ihn H; Oike Y Cancer Res; 2011 Dec; 71(24):7502-12. PubMed ID: 22042794 [TBL] [Abstract][Full Text] [Related]
15. Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells. Elkabets M; Krelin Y; Dotan S; Cerwenka A; Porgador A; Lichtenstein RG; White MR; Zoller M; Iwakura Y; Dinarello CA; Voronov E; Apte RN J Immunol; 2009 Apr; 182(8):4874-81. PubMed ID: 19342666 [TBL] [Abstract][Full Text] [Related]
16. [Enhancement of HSP-MUC1 antitumor activity by type C CpG-ODN BW005]. Wang XJ; Wang ZB; Wei HF; Wu XL; Wang L; Yu YL; Wang LY Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):338-40. PubMed ID: 17428390 [TBL] [Abstract][Full Text] [Related]
17. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases]. Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapeutic effects of novel CpG ODN in murine tumor model. Cho HC; Kim BH; Kim K; Park JY; Chang JH; Kim SK Int Immunopharmacol; 2008 Oct; 8(10):1401-7. PubMed ID: 18687302 [TBL] [Abstract][Full Text] [Related]
19. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432 [TBL] [Abstract][Full Text] [Related]
20. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines. Ahn YO; Lee JC; Sung MW; Heo DS J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]